Enumeral Biomedical Holdings, Inc. company info

CIK 1561551
IRS Number 990376434
State of incorporation DE
Business address 200 CAMBRIDGEPARK DRIVE, SUITE 2000
Mail address 200 CAMBRIDGEPARK DRIVE, SUITE 2000

Short summary

Enumeral Biomedical Holdings, Inc. is a Massachusetts company, with head office located at 200 Cambridgepark Drive, Suite 2000 Cambridge, Massachusetts 02140. In 2017 the company owned a total of 528.54 thousand USD worth of assets, including 523.54 thousand USD worth of current assets. 2014 was the year when the company amassed the most assets.

Enumeral Biomedical Holdings, Inc. Income Statement

Name [in Millions USD]2011201220132014201520162017Trends
Revenue, Net 0.161.49
Research and development 1.832.373.586.494.87
Operating Expenses
Operating Income (Loss) -3.14-3.75-6.43-10.70-6.97
Interest expense
Other Nonoperating Income (Expense) -0.000.00-1.69
Income Tax Expense (Benefit)
Net income -3.25-3.86-8.183.29-11.86

Enumeral Biomedical Holdings, Inc. Balance Sheet

Name [in Millions USD]2011201220132014201520162017Trends
Cash and cash equivalents 1.711.140.608.381.130.580.21
Accounts Receivable, Net, Current 0.050.330.420.09
Property, Plant and Equipment, Gross 1.241.322.312.90
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 0.270.691.041.74
Other Assets, Noncurrent
Total assets 0.001.5810.783.490.990.53
Current assets 0.000.918.941.690.980.52
Non-current assets 0.11
Accounts payable 0.000.550.390.350.690.69
Total current liabilities 1.301.709.823.131.611.69
Long-term Debt, Excluding Current Maturities 1.050.04
Long-term Debt 1.47
Deferred Revenue, Noncurrent 00.09
Total liabilities
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -0.01-11.91-15.43-17.31-31.42-31.99
Accumulated Other Comprehensive Income (Loss), Net of Tax 0

Enumeral Biomedical Holdings, Inc. Cash Flow

Name [in Millions USD]2011201220132014201520162017Trends
Net income -3.25-3.86-8.183.29-11.86
Depreciation and amortization
Depreciation and amortization
Accounts receivable
Accounts payable 0.00
Deferred revenue 0.07-0.050.21-0.11-0.12
Net Cash Provided by (Used in) Operating Activities -2.65-3.31-5.24-9.29
Payments to Acquire Property, Plant, and Equipment 0.540.060.561.05
Net Cash Provided by (Used in) Investing Activities -0.57-0.06-4.111.98
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -4.111.98
Proceeds from Issuance of Long-term Debt 0.64
Proceeds from Issuance of Common Stock 0.06
Net Cash Provided by (Used in) Financing Activities 3.261.8919.550.44
Cash and Cash Equivalents, Period Increase (Decrease) 0.04-1.4810.20-6.86-0.43